false Q1 --12-31 0001069394 0001069394 2026-01-01 2026-03-31 0001069394 2026-05-15 0001069394 2026-03-31 0001069394 2025-12-31 0001069394 2025-01-01 2025-03-31 0001069394 2024-12-31 0001069394 2025-03-31 0001069394 us-gaap:CommonStockMember 2025-12-31 0001069394 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001069394 us-gaap:RetainedEarningsMember 2025-12-31 0001069394 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001069394 us-gaap:ParentMember 2025-12-31 0001069394 us-gaap:NoncontrollingInterestMember 2025-12-31 0001069394 us-gaap:CommonStockMember 2024-12-31 0001069394 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001069394 us-gaap:RetainedEarningsMember 2024-12-31 0001069394 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001069394 us-gaap:ParentMember 2024-12-31 0001069394 us-gaap:NoncontrollingInterestMember 2024-12-31 0001069394 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001069394 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001069394 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001069394 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001069394 us-gaap:ParentMember 2026-01-01 2026-03-31 0001069394 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0001069394 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001069394 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001069394 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001069394 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001069394 us-gaap:ParentMember 2025-01-01 2025-03-31 0001069394 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001069394 us-gaap:CommonStockMember 2026-03-31 0001069394 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001069394 us-gaap:RetainedEarningsMember 2026-03-31 0001069394 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001069394 us-gaap:ParentMember 2026-03-31 0001069394 us-gaap:NoncontrollingInterestMember 2026-03-31 0001069394 us-gaap:CommonStockMember 2025-03-31 0001069394 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001069394 us-gaap:RetainedEarningsMember 2025-03-31 0001069394 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001069394 us-gaap:ParentMember 2025-03-31 0001069394 us-gaap:NoncontrollingInterestMember 2025-03-31 0001069394 FSI:ENPInvestmentsLLCAndENPMendotaMember 2026-01-01 2026-03-31 0001069394 FSI:MendotaLLCMember 2026-01-01 2026-03-31 0001069394 FSI:MendotaLLCMember 2023-01-01 2023-12-31 0001069394 FSI:MendotaLLCMember FSI:UnrelatedPartyMember 2023-12-31 0001069394 FSI:FirstTermMember 2026-03-31 0001069394 FSI:SecondTermMember 2026-03-31 0001069394 FSI:ThirdTermMember 2026-03-31 0001069394 us-gaap:ShippingAndHandlingMember 2026-01-01 2026-03-31 0001069394 us-gaap:ShippingAndHandlingMember 2025-01-01 2025-03-31 0001069394 FSI:ThreePrimaryCustomersMember us-gaap:RevenueFromContractWithCustomerMember 2026-01-01 2026-03-31 0001069394 FSI:ThreePrimaryCustomersMember us-gaap:RevenueFromContractWithCustomerMember 2025-01-01 2025-03-31 0001069394 FSI:ThreePrimaryCustomersMember us-gaap:AccountsReceivableMember 2026-01-01 2026-03-31 0001069394 FSI:ThreePrimaryCustomersMember us-gaap:AccountsReceivableMember 2025-01-01 2025-12-31 0001069394 FSI:PanamaOperatingLeaseMember 2024-12-31 0001069394 FSI:PanamaOperatingLeaseMember 2024-01-01 2024-12-31 0001069394 srt:MaximumMember FSI:PanamaOperatingLeaseMember 2024-01-01 2024-12-31 0001069394 FSI:PanamaOperatingLeaseMember 2026-03-31 0001069394 FSI:PanamaOperatingLeaseMember 2025-12-31 0001069394 FSI:PanamaOperatingLeaseMember 2026-01-01 2026-03-31 0001069394 FSI:PanamaOperatingLeaseMember 2025-01-01 2025-03-31 0001069394 FSI:MendotaIllinoisOperatingLeaseMember 2025-10-31 0001069394 FSI:MendotaIllinoisOperatingLeaseMember 2025-10-01 2025-10-31 0001069394 FSI:MendotaIllinoisOperatingLeaseSectionAMember 2025-10-31 0001069394 FSI:MendotaIllinoisOperatingLeaseSectionAMember 2025-10-01 2025-10-31 0001069394 FSI:MendotaIllinoisOperatingLeaseSectionAMember 2026-03-31 0001069394 FSI:MendotaIllinoisOperatingLeaseSectionAMember 2025-12-31 0001069394 us-gaap:SellingGeneralAndAdministrativeExpense FSI:MendotaIllinoisOperatingLeaseSectionAMember 2026-01-01 2026-03-31 0001069394 us-gaap:SellingGeneralAndAdministrativeExpense FSI:MendotaIllinoisOperatingLeaseSectionAMember 2025-01-01 2025-03-31 0001069394 FSI:MendotaIllinoisOperatingLeaseSectionBMember 2025-10-31 0001069394 FSI:MendotaIllinoisOperatingLeaseSectionBMember 2025-10-01 2025-10-31 0001069394 FSI:MendotaIllinoisOperatingLeaseSectionBMember 2026-03-31 0001069394 FSI:MendotaIllinoisOperatingLeaseSectionBMember 2025-12-31 0001069394 us-gaap:SellingGeneralAndAdministrativeExpense FSI:MendotaIllinoisOperatingLeaseSectionBMember 2026-01-01 2026-03-31 0001069394 us-gaap:SellingGeneralAndAdministrativeExpense FSI:MendotaIllinoisOperatingLeaseSectionBMember 2025-01-01 2025-03-31 0001069394 FSI:MendotaILOperatingLeaseMember 2026-03-31 0001069394 us-gaap:BuildingAndBuildingImprovementsMember 2026-03-31 0001069394 us-gaap:AutomobilesMember 2026-03-31 0001069394 us-gaap:OfficeEquipmentMember 2026-03-31 0001069394 us-gaap:MachineryAndEquipmentMember 2026-03-31 0001069394 us-gaap:LandMember 2026-03-31 0001069394 FSI:TechnologyMember 2026-03-31 0001069394 us-gaap:BuildingAndBuildingImprovementsMember 2025-12-31 0001069394 us-gaap:AutomobilesMember 2025-12-31 0001069394 us-gaap:OfficeEquipmentMember 2025-12-31 0001069394 us-gaap:MachineryAndEquipmentMember 2025-12-31 0001069394 us-gaap:LandMember 2025-12-31 0001069394 FSI:TechnologyMember 2025-12-31 0001069394 FSI:FloridaBasedLLCMember 2026-01-01 2026-03-31 0001069394 FSI:TrioOpportunityCorpMember 2026-03-31 0001069394 FSI:TrioOpportunityCorpMember 2025-12-31 0001069394 FSI:FloridaBasedLLCMember 2026-03-31 0001069394 FSI:FloridaBasedLLCMember 2025-12-31 0001069394 us-gaap:CommonClassBMember FSI:TrioOpportunityCorpMember 2026-03-31 0001069394 FSI:FloridaBasedLLCMember 2019-01-31 0001069394 FSI:FloridaBasedLLCMember 2024-08-31 0001069394 FSI:FloridaBasedLLCMember 2024-08-01 2024-08-31 0001069394 FSI:FloridaBasedLLCMember 2025-01-01 0001069394 2025-01-01 2025-12-31 0001069394 FSI:FloridaBasedLLCMember 2025-01-01 2025-03-31 0001069394 FSI:FloridaBasedLLCMember 2024-12-31 0001069394 FSI:FloridaBasedLLCMember 2025-12-31 0001069394 FSI:FloridaBasedLLCMember 2026-03-31 0001069394 FSI:FloridaBasedLLCMember 2024-12-31 0001069394 FSI:FloridaBasedLLCMember 2025-01-01 2025-12-31 0001069394 FSI:StockBankMember FSI:ENPInvestmentsLLCMember FSI:NewAgreementMember 2025-06-30 0001069394 FSI:StockBankMember FSI:ENPInvestmentsLLCMember FSI:NewAgreementMember srt:MinimumMember 2025-06-01 2025-06-30 0001069394 FSI:StockBankMember FSI:ENPInvestmentsLLCMember FSI:NewAgreementMember srt:MaximumMember 2025-06-01 2025-06-30 0001069394 FSI:StockBankMember FSI:ENPInvestmentsLLCMember FSI:NewAgreementMember 2025-06-01 2025-06-30 0001069394 FSI:StockBankMember FSI:ENPInvestmentsLLCMember FSI:NewAgreementMember 2026-03-31 0001069394 FSI:StockBankMember FSI:ENPInvestmentsLLCMember FSI:NewAgreementMember 2025-12-31 0001069394 FSI:StockBankMember FSI:NewAgreementMember FSI:NanoChemSolutionIncMember 2025-06-30 0001069394 FSI:NewAgreementMember FSI:NanoChemSolutionIncMember FSI:StockYardAndBankMember 2025-06-30 0001069394 FSI:NoncontrollingInterestsMember FSI:StockBankMember 2025-06-30 0001069394 FSI:StockBankMember FSI:NewAgreementMember 2025-08-31 0001069394 FSI:StockBankMember FSI:NewAgreementMember 2025-08-01 2025-08-31 0001069394 FSI:StockBankMember FSI:NewAgreementMember 2026-03-31 0001069394 FSI:StockBankMember FSI:NewAgreementMember 2025-12-31 0001069394 FSI:StockYardsBankAndTrustMember FSI:TermLoanMember FSI:ENPMendotaMember 2026-03-31 0001069394 FSI:StockYardsBankAndTrustMember FSI:TermLoanMember FSI:ENPMendotaMember 2025-12-31 0001069394 FSI:StockYardsBankAndTrustMember FSI:TermLoanMember FSI:ENPPeruOneMember 2026-03-31 0001069394 FSI:StockYardsBankAndTrustMember FSI:TermLoanMember FSI:ENPPeruOneMember 2025-12-31 0001069394 FSI:StockYardsBankAndTrustMember FSI:ENPPeruTwoMember FSI:TermLoanMember 2026-03-31 0001069394 FSI:StockYardsBankAndTrustMember FSI:ENPPeruTwoMember FSI:TermLoanMember 2025-12-31 0001069394 FSI:StockYardsBankAndTrustMember FSI:NanoChemOneMember FSI:TermLoanMember 2026-03-31 0001069394 FSI:StockYardsBankAndTrustMember FSI:NanoChemOneMember FSI:TermLoanMember 2025-12-31 0001069394 FSI:StockYardsBankAndTrustMember 2026-03-31 0001069394 FSI:StockYardsBankAndTrustMember 2025-12-31 0001069394 FSI:TermLoanMember FSI:ENPMendotaMember 2026-01-01 2026-03-31 0001069394 FSI:TermLoanMember FSI:ENPMendotaMember 2025-01-01 2025-12-31 0001069394 FSI:TermLoanMember FSI:ENPMendotaMember 2026-03-31 0001069394 FSI:TermLoanMember FSI:ENPMendotaMember 2025-12-31 0001069394 FSI:TermLoanMember FSI:ENPPeruOneMember 2025-01-01 2025-12-31 0001069394 FSI:TermLoanMember FSI:ENPPeruOneMember 2026-03-31 0001069394 FSI:TermLoanMember FSI:ENPPeruInvestmentsMember 2026-01-01 2026-03-31 0001069394 FSI:TermLoanMember FSI:ENPPeruInvestmentsMember 2025-01-01 2025-12-31 0001069394 FSI:TermLoanMember FSI:ENPPeruInvestmentsMember 2026-03-31 0001069394 FSI:TermLoanMember FSI:ENPPeruInvestmentsMember 2025-12-31 0001069394 FSI:TermLoanMember FSI:NanoChemTwoMember 2026-01-01 2026-03-31 0001069394 FSI:TermLoanMember FSI:NanoChemTwoMember 2025-01-01 2025-12-31 0001069394 FSI:TermLoanMember FSI:NanoChemTwoMember 2026-03-31 0001069394 FSI:TermLoanMember FSI:NanoChemTwoMember 2025-12-31 0001069394 us-gaap:EmployeeStockOptionMember us-gaap:SalariesAndWages 2026-01-01 2026-03-31 0001069394 us-gaap:EmployeeStockOptionMember us-gaap:SalariesAndWages 2025-01-01 2025-03-31 0001069394 us-gaap:EmployeeStockOptionMember us-gaap:ProfessionalFees 2026-01-01 2026-03-31 0001069394 us-gaap:EmployeeStockOptionMember us-gaap:ProfessionalFees 2025-01-01 2025-03-31 0001069394 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001069394 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001069394 srt:MinimumMember 2024-12-31 0001069394 srt:MaximumMember 2024-12-31 0001069394 srt:MinimumMember 2025-01-01 2025-12-31 0001069394 srt:MaximumMember 2025-01-01 2025-12-31 0001069394 srt:MinimumMember 2025-12-31 0001069394 srt:MaximumMember 2025-12-31 0001069394 srt:MinimumMember 2026-01-01 2026-03-31 0001069394 srt:MaximumMember 2026-01-01 2026-03-31 0001069394 srt:MinimumMember 2026-03-31 0001069394 srt:MaximumMember 2026-03-31 0001069394 us-gaap:CanadaRevenueAgencyMember 2026-03-31 0001069394 us-gaap:CanadaRevenueAgencyMember 2026-01-01 2026-03-31 0001069394 us-gaap:CanadaRevenueAgencyMember 2025-01-01 2025-03-31 0001069394 FSI:ENPInvestmentsLLCMember 2026-01-01 2026-03-31 0001069394 FSI:ENPInvestmentsLLCMember 2026-03-31 0001069394 FSI:ENPInvestmentsLLCMember 2025-01-01 2025-03-31 0001069394 FSI:ENPInvestmentsLLCMember 2025-12-31 0001069394 FSI:MendotaLLCMember 2026-03-31 0001069394 FSI:ENPInvestmentsLLCMember FSI:OwnershipInterestPurchaseAgreementMember 2024-12-31 0001069394 FSI:ENPInvestmentsLLCMember FSI:OwnershipInterestPurchaseAgreementMember 2025-01-01 2025-12-31 0001069394 FSI:ENPInvestmentsLLCMember FSI:OwnershipInterestPurchaseAgreementMember 2025-12-31 0001069394 FSI:ENPInvestmentsLLCMember FSI:OwnershipInterestPurchaseAgreementMember 2026-01-01 2026-03-31 0001069394 FSI:ENPInvestmentsLLCMember FSI:OwnershipInterestPurchaseAgreementMember 2026-03-31 0001069394 FSI:MendotaLLCMember FSI:OwnershipInterestPurchaseAgreementMember 2024-12-31 0001069394 FSI:MendotaLLCMember FSI:OwnershipInterestPurchaseAgreementMember 2025-01-01 2025-12-31 0001069394 FSI:MendotaLLCMember FSI:OwnershipInterestPurchaseAgreementMember 2025-12-31 0001069394 FSI:MendotaLLCMember FSI:OwnershipInterestPurchaseAgreementMember 2026-01-01 2026-03-31 0001069394 FSI:MendotaLLCMember FSI:OwnershipInterestPurchaseAgreementMember 2026-03-31 0001069394 us-gaap:AccountsReceivableMember FSI:ThreeCustomersMember 2026-03-31 0001069394 us-gaap:AccountsReceivableMember FSI:ThreeCustomersMember 2025-03-31 0001069394 FSI:EWCPMember FSI:SegmentMember 2026-01-01 2026-03-31 0001069394 FSI:BCPAMember FSI:SegmentMember 2026-01-01 2026-03-31 0001069394 FSI:SegmentMember FSI:OtherMember 2026-01-01 2026-03-31 0001069394 FSI:SegmentMember 2026-01-01 2026-03-31 0001069394 FSI:EWCPMember FSI:SegmentMember 2026-03-31 0001069394 FSI:BCPAMember FSI:SegmentMember 2026-03-31 0001069394 FSI:SegmentMember FSI:OtherMember 2026-03-31 0001069394 FSI:SegmentMember 2026-03-31 0001069394 FSI:EWCPMember FSI:SegmentMember 2025-01-01 2025-03-31 0001069394 FSI:BCPAMember FSI:SegmentMember 2025-01-01 2025-03-31 0001069394 FSI:SegmentMember FSI:OtherMember 2025-01-01 2025-03-31 0001069394 FSI:SegmentMember 2025-01-01 2025-03-31 0001069394 FSI:EWCPMember FSI:SegmentMember 2025-12-31 0001069394 FSI:BCPAMember FSI:SegmentMember 2025-12-31 0001069394 FSI:OtherMember FSI:SegmentMember 2025-12-31 0001069394 FSI:SegmentMember 2025-12-31 0001069394 country:CA 2026-01-01 2026-03-31 0001069394 country:CA 2025-01-01 2025-03-31 0001069394 FSI:UnitedStatesandAbroadMember 2026-01-01 2026-03-31 0001069394 FSI:UnitedStatesandAbroadMember 2025-01-01 2025-03-31 0001069394 country:CA 2026-03-31 0001069394 country:CA 2025-12-31 0001069394 country:US 2026-03-31 0001069394 country:US 2025-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure FSI:Segments utr:sqft

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2026

 

OR

 

TRANSITION REPORT PURSUANT TO 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File Number: 001-31540

 

FLEXIBLE SOLUTIONS INTERNATIONAL INC.

(Exact Name of registrant as Specified in Its Charter)

 

Alberta   71-1630889
(State or other jurisdiction of   (Employer
incorporation or organization)   Identification No.)
     
6001 54 Ave.    
Taber, Alberta, Canada   T1G 1X4
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number: (403) 223-2995

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   FSI   NYSE American

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
   
Non-accelerated filer Smaller reporting company
   
Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): ☐ Yes No

 

Class of Stock   No. Shares Outstanding   Date
Common   12,737,498   May 15, 2026

 

 

 

 

 

 

FORM 10-Q

 

Index

 

PART I. FINANCIAL INFORMATION 3
       
Item 1. Financial Statements. 3
       
  (a) Unaudited Condensed Interim Consolidated Balance Sheets at March 31, 2026 and December 31, 2025. 3
       
  (b) Unaudited Condensed Interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three Months Ended March 31, 2026 and 2025. 4
       
  (c) Unaudited Condensed Interim Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025. 5
       
  (d) Unaudited Condensed Interim Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2026 and 2025. 6
       
  (e) Notes to Unaudited Condensed Interim Consolidated Financial Statements for the Period Ended March 31, 2026. 8
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 19
       
Item 4. Controls and Procedures. 21
       
PART II. OTHER INFORMATION 22
       
Item 5. Other Information. 22
       
Item 6. Exhibits. 22
       
SIGNATURES 23

 

1

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are “forward-looking statements” for the purposes of the federal and state securities laws, including, but not limited to: any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing.

 

Forward-looking statements may include the words “may,” “could,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” or other similar words. These forward-looking statements present our estimates and assumptions only as of the date of this report. Except for our ongoing obligation to disclose material information as required by the federal securities laws, we do not intend, and undertake no obligation, to update any forward-looking statement.

 

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties. The factors impacting these risks and uncertainties include but are not limited to:

 

  Increased competitive pressures from existing competitors and new entrants;
     
  Increases in interest rates or our cost of borrowing or a default under any material debt agreement;
     
  Deterioration in general or regional economic conditions;
     
  Adverse state or federal legislation or regulation that increases the costs of compliance, or adverse findings by a regulator with respect to existing operations;
     
  Loss of customers or sales weakness;
     
  Inability to achieve future sales levels or other operating results;
     
  The unavailability of funds for capital expenditures;
     
  Operational inefficiencies in distribution or other systems; and
     
  New tariffs relating to raw materials imported from China.

 

For a detailed description of these and other factors that could cause actual results to differ materially from those expressed in any forward-looking statement, please see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025.

 

2

 

 

PART I FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

FLEXIBLE SOLUTIONS INTERNATIONAL, INC.

CONDENSED INTERIM CONSOLIDATED BALANCE SHEETS

(U.S. Dollars - Unaudited)

 

   March 31, 2026   December 31, 2025 
Assets          
Current          
Cash  $5,821,779   $6,625,748 
Term deposits (Note 2)   652,810    1,386,150 
Accounts receivable, net (Note 4)   13,390,388    12,621,901 
Inventories (Note 5)   12,522,356    10,541,637 
Prepaid expenses and deposits   1,436,211    1,326,637 
Property held for sale   425,000    425,000 
Total current assets   34,248,544    32,927,073 
Property, equipment and leaseholds, net (Note 6)   17,906,361    16,142,092 
Right of use assets, net (Note 3)   3,678,552    3,790,687 
Intangible assets   1,920,000    1,960,000 
Long term deposits   1,643,595    2,423,928 
Investments (Note 7)   2,000,236    2,054,324 
Goodwill   2,534,275    2,534,275 
Total Assets  $63,931,563   $61,832,379 
           
Liabilities          
Current          
Accounts payable  $2,585,356   $2,221,411 
Accrued liabilities   171,097    501,175 
Deferred revenue   132,881    124,944 
Income taxes payable   4,803,244    5,061,317 
Short term lines of credit (Note 8)   4,796,444    2,148,386 
Current portion of lease liabilities (Note 3)   466,972    299,445 
Current portion of long-term debt (Note 9)   414,205    396,961 
Total current liabilities   13,370,199    10,753,639 
Right of use liabilities, net (Note 3)   3,730,815    3,923,938 
Deferred income tax liability   277,417    277,417 
Long term debt (Note 9)   3,925,819    4,044,699 
Total Liabilities   21,304,250    18,999,693 
Commitments and Contingencies (Notes 8 and 9)   -     -  
           
Stockholders’ Equity          
Capital stock (Note 11)          
Authorized: 50,000,000 common shares with a par value of $0.001 each; 1,000,000 preferred shares with a par value of $0.01 each Issued and outstanding: 12,737,498 (December 31, 2025: 12,722,498) common shares  $12,738   $12,723 
Capital in excess of par value   20,128,846    19,895,935 
Accumulated other comprehensive loss   (434,170)   (347,887)
Accumulated earnings   19,107,248    19,348,668 
Total stockholders’ equity – Flexible Solutions International Inc.   38,814,662    38,909,439 
Non-controlling interests (Note 12)   3,812,651    3,923,247 
Total Stockholders’ Equity   42,627,313    42,832,686 
Total Liabilities and Stockholders’ Equity  $63,931,563   $61,832,379 

 

— See Notes to Unaudited Condensed Interim Consolidated Financial Statements —

 

3

 

 

FLEXIBLE SOLUTIONS INTERNATIONAL, INC.

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(U.S. Dollars — Unaudited)

 

   Three Months Ended March 31, 
   2026   2025 
Sales          
Products  $8,296,997   $7,473,692 
Cost of sales   6,407,691    5,522,128 
Gross profit   1,889,306    1,951,564 
Operating expenses          
Professional fees   69,295    262,633 
Research and development   116,533    106,801 
Selling, general, and administrative   762,357    756,050 
Wages, administrative salaries and benefits   1,027,086    895,237 
Total operating expenses   1,975,271    2,020,721 
Operating loss   (85,965)   (69,157)
Non-operating income (expense)          
(Loss) income from investments (Note 7)   (54,088)   63,925 
Interest expense   (134,069)   (198,019)
Interest income   37,446    49,573 
Total non-operating expense   (150,711)   (84,521)
Loss before income tax   (236,676)   (153,678)
Income taxes          
Current income tax expense   (46,681)   (110,363)
Net loss   (283,357)   (264,041)
Net loss (income) attributable to non-controlling interests   41,937    (13,693)
Net loss attributable to Flexible Solutions International Inc.  $(241,420)  $(277,734)
           
Loss per share (basic)  $(0.02)  $(0.02)
Loss per share (diluted)  $(0.02)  $(0.02)
Weighted average number of common shares (basic)   12,735,609    12,587,476 
Weighted average number of common shares (diluted)   12,735,609    12,587,476 
           
Other comprehensive income (loss):          
Net loss  $(283,357)  $(264,041)
Unrealized gain (loss) on foreign currency translations   (86,283)   188,840 
Total comprehensive loss   (369,640)   (75,201)
Comprehensive loss (income) – non-controlling interests   41,937    (13,693)
Comprehensive loss attributable to controlling interest  $(327,703)  $(88,894)

 

— See Notes to Unaudited Condensed Interim Consolidated Financial Statements —

 

4

 

 

FLEXIBLE SOLUTIONS INTERNATIONAL, INC.

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. Dollars — Unaudited)

 

       
   Three Months Ended March 31, 
   2026   2025 
         
Operating activities          
Net loss for the period  $(283,357)  $(264,041)
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Stock based compensation   109,773    97,920 
Depreciation and amortization   509,495    465,198 
Non cash operating lease expense   86,539    - 
Loss (income) from investments   54,088    (63,925)
           
Changes in operating assets and liabilities:          
Accounts receivable   (768,487)   (280,391)
Inventories   (1,980,719)   (237,544)
Prepaid expenses and deposits   (109,574)   3,569 
Long term deposits   780,333    (259,023)
Accounts payable   363,946    107,985 
Accrued liabilities   (330,078)   (223,183)
Deferred revenue   7,937    (1,222)
Income taxes payable   (258,073)   110,363 
           
Cash used in operating activities   (1,818,177)   (544,294)
           
Investing activities          
Maturities of term deposits, net   733,340    1,019,760 
Purchase of property, equipment and leaseholds   (2,233,765)   (354,121)
           
Cash provided by (used in) investing activities   (1,500,425)   665,639
           
Financing activities          
Proceeds from short-term lines of credit, net   2,648,058    1,938,670 
Repayment of long-term debt   (101,636)   (616,343)
Distribution to non-controlling interest   (68,659)   - 
Distribution received upon dissolution of subsidiary   72,953    - 
Proceeds from shares issued upon exercise of stock options   50,200    381,690 
           
Cash provided by financing activities   2,600,916    1,704,017 
           
Effect of exchange rate changes on cash   (86,283)   188,840 
           
Increase (decrease) in cash   (803,969)   2,014,202 
Cash, beginning of year   6,625,748    7,631,055 
           
Cash, end of period  $5,821,779   $9,645,257 

 

— See Notes to Unaudited Condensed Interim Consolidated Financial Statements —

 

5

 

 

FLEXIBLE SOLUTIONS INTERNATIONAL, INC.

CONDENSED INTERIM Consolidated Statements of Stockholders’ Equity

(U.S. Dollars – Unaudited)

 

                          
   Shares   Capital Stock  

Capital in

Excess of

Par Value

  

Accumulated

Earnings

  

Accumulated Other

Comprehensive

Loss

   Total  

Non-

Controlling Interests

  

Total

Stockholders’

Equity

 
                                 
Balance December 31, 2025   12,722,498   $12,723   $19,895,935   $19,348,668   $(347,887)  $38,909,439   $3,923,247   $   42,832,686 
Translation adjustment                   (86,283)   (86,283)       (86,283)
Net income (loss)               (241,420)       (241,420)   (41,937)   (283,357)
Distribution to noncontrolling interest                           (68,659)   (68,659)
Distribution received upon dissolution of subsidiary             

72,953

             72,953         72,953 
Common stock issued upon exercise of options   15,000    15    50,185            50,200        50,200 
Stock-based compensation           109,773            109,773        109,773 
                                         
Balance March 31, 2026   12,737,498   $12,738   $20,128,846   $19,107,248   $(434,170)  $38,814,662   $3,812,651   $42,627,313 

 

— See Notes to Unaudited Condensed Interim Consolidated Financial Statements —

 

6

 

 

FLEXIBLE SOLUTIONS INTERNATIONAL, INC.

CONDENSED INTERIM Consolidated Statements of Stockholders’ Equity

(U.S. Dollars – Unaudited)

 

   Shares   Capital Stock  

Capital in

Excess of

Par Value

  

Accumulated

Earnings

  

Other

Comprehensive

Loss

   Total  

Non-

Controlling Interests

  

Total

Stockholders’

Equity

 
                                 
Balance December 31, 2024    12,515,532   $12,516   $18,789,915   $19,836,527   $(606,986)  $38,031,972   $3,334,054   $   41,366,026 
Translation adjustment                    188,840    188,840        188,840 
Net income (loss)                (277,734)       (277,734)   13,693    (264,041)
                                         
Common stock issued upon exercise of options    132,000    132    381,558            381,690        381,690 
Stock-based compensation            97,920            97,920        97,920 
                                         
Balance March 31, 2025    12,647,532   $12,648   $19,269,393   $19,558,793   $(418,146)  $38,422,688   $3,347,747   $41,770,435 

 

— See Notes to Unaudited Condensed Interim Consolidated Financial Statements —

 

7

 

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

For the Three Months Ended March 31, 2026

(U.S. Dollars - Unaudited)

 

1. BASIS OF PRESENTATION

 

These condensed interim consolidated financial statements include the accounts of Flexible Solutions International, Inc. (the “Company”), its wholly-owned subsidiaries Flexible Fermentation Ltd., NanoChem Solutions Inc. (“NanoChem”), Flexible Solutions Ltd., Flexible Biomass LP, FS Biomass Inc., NCS Deferred Corp., Natural Chem SEZC Ltd. (“Natural Chem”), Pana Chem Solutions Inc. (“Pana Chem”), InnFlex Holdings Inc., ENP Peru Investments LLC (“ENP Peru”), its 65% controlling interest in ENP Investments, LLC (“ENP Investments”) and ENP Mendota, LLC (“ENP Mendota”) and its former 80% controlling interest in 317 Mendota LLC (“317 Mendota”) that was dissolved in March 2026 (see Note 12). All inter-company balances and transactions have been eliminated upon consolidation. The Company was incorporated on May 12, 1998 in the State of Nevada and in 2019 the Company redomiciled into Alberta, Canada.

 

In 2023, the Company purchased an 80% interest in 317 Mendota, a newly incorporated company established to purchase a large manufacturing building. The remaining 20% non-controlling interest was held by unrelated parties. The manufacturing building was sold in October 2025 and ENP Investments leases space in building from the new owner (see Note 3).

 

The Company and its subsidiaries develop, manufacture and market specialty chemicals which slow the evaporation of water. One product, HEATSAVR®, is marketed for use in swimming pools and spas where its use, by slowing the evaporation of water, allows the water to retain a higher temperature for a longer period of time and thereby reduces the energy required to maintain the desired temperature of the water in the pool. Another product, WATERSAVR®, is marketed for water conservation in irrigation canals, aquaculture, and reservoirs where its use slows water loss due to evaporation. In addition to the water conservation products, the Company also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers (hereinafter referred to as “TPAs”), which are beta-proteins manufactured from the common biological amino acid, L-aspartic. TPAs can be formulated to prevent corrosion and scaling in water piping within the petroleum, chemical, utility and mining industries. TPAs are also used as proteins to enhance fertilizers in improving crop yields and can be used as additives for household laundry detergents, consumer care products and pesticides. The TPA division also manufactures two nitrogen conservation products for agriculture that slows nitrogen loss from fields and has installed custom equipment for production of food and nutritional materials. All the ingredients the Company produces are custom products for specific clients and are confidential. The Company anticipates that this market vertical will grow over time. The Company also manufactures food grade products that are made and sold by the TPA division. The TPA division recognizes research and development income from time to time.

 

2. SIGNIFICANT ACCOUNTING POLICIES

 

These condensed interim consolidated financial statements have been prepared on a historical cost basis, except where otherwise noted, in accordance with accounting principles generally accepted in the United States applicable to a going concern and reflect the policies outlined below.

 

In the opinion of management, the accompanying unaudited condensed interim consolidated financial statements contain all adjustments (all of which are of a normal recurring nature) and disclosures necessary for a fair statement of the Company’s financial position as of March 31, 2026 and the results of its operations and cash flows for the three months then ended. The consolidated balance sheet as of December 31, 2025 is derived from the December 31, 2025 audited financial statements. The unaudited condensed interim consolidated financial statements do not include all disclosures required of annual consolidated financial statements and, accordingly, should be read in conjunction with our annual financial statements for the year ended December 31, 2025. Operating results for the three months ended March 31, 2026 may not be indicative of results expected for the full year ending December 31, 2026.

 

8

 

 

The Company recorded income tax expense for the three months ended March 31, 2026 despite reporting a pre-tax loss. The estimated effective tax rate for the period differs from the U.S. federal statutory rate primarily due to the accrual of interest and penalties on unfiled federal and state tax returns. The uncertain tax position underlying these returns was resolved during the year ended December 31, 2025, but interest and penalties continue to accrue until the returns are filed. These amounts are recognized as a component of income tax expense.

 

(a) Term Deposits.

 

Term deposits with original maturities greater than three months but less than one year are classified as current assets and carried at amortized cost, which approximates fair value. Interest income is recognized on the accrual basis.

 

At March 31, 2026, the Company had two term deposits that are maintained by commercial banks. The first term deposit is for $322,752 and matures in February 2027. This deposit pays 3% interest and, if withdrawn before maturity, a penalty may be applied. The second term deposit is for $330,058, matures in August 2026 and pays interest at a rate of 3%. If withdrawn before maturity, a penalty may be applied. A third term deposit for $761,074, matured in March 2026 and was not renewed.

 

(b) Inventories and Cost of Sales.

 

The Company has three major classes of inventory: completed goods, work in progress and raw materials and supplies. In all classes, inventories are stated at the lower of cost or net realizable value with cost determined using either weighted average cost or the first-in, first-out (FIFO) method, depending on the entity. Cost of sales includes all expenditures incurred in bringing the goods to the point of sale. Inventory costs and costs of sales include direct costs of the raw material, inbound freight charges, warehousing costs, handling costs (receiving and purchasing) and utilities and overhead expenses related to the Company’s manufacturing and processing facilities. The Company periodically reviews its inventory for slow-moving or obsolete items and writes down the inventory carrying value to its estimated net realizable value based on assumptions about future demand and market conditions.

 

The Company accounts for shipping and handling activities as fulfillment costs and shipping and handling charges included in the consolidated statements of income and comprehensive income are as follows:

 

       
   Three Months Ended March 31, 
   2026   2025 
         
Shipping income in product sales  $108,799   $76,066 
Shipping costs in cost of sales  $163,462   $158,768 

 

(c) Risk Management and Concentrations.

 

The Company’s credit risk is primarily attributable to its accounts receivable. The amounts presented in the consolidated balance sheets are net of allowances for doubtful accounts, estimated by the Company’s management based on prior experience and the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure is minimized by dealing with only credit worthy counterparties.

 

Total revenue for the Company’s three primary customers in each period is as follows:

 

 SCHEDULE OF RESEARCH AND DEVELOPMENT SERVICES REVENUE

   Three months ended
March 31,
 
   2026   2025 
         
Total revenue for three primary customers  $4,639,124   $3,665,235 
Total revenue for three primary customers as a percentage of sales   56%   49%

 

9

 

 

Total accounts receivable for the Company’s three primary product sales customers for the three months ended March 31, 2026 and the full year December 31, 2025 is as follows:

 

   March 31, 2026   December 31, 2025 
           
Accounts receivable of three primary customers  $9,057,268 (68)%  $7,826,250 (62)%

 

The credit risk on cash is limited because the Company limits its exposure to credit loss by placing its cash with major financial institutions. The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced any losses in such accounts.

 

(d) Reclassification.

 

Certain prior year amounts have been reclassified to conform to the 2026 financial statements presentation. Reclassifications had no effect on net income (loss), cash flows, or stockholders’ equity as previously reported.

 

(e) Recent Accounting Pronouncements.

 

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure about the types of costs and expenses included in certain expense captions presented on the income statement. The new disclosure requirements are effective for the Company’s annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating the ASU to determine its impact on its condensed interim consolidated financial statements and disclosures.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

 

10

 

 

3. LEASES

 

Panama Operating Lease

 

In 2024, the Company executed a contract to lease 37,500 sq. ft for manufacturing space with a lease term of 122 months with the option to renew the lease for a further 36 months at the end and total payments during the term, starting at $31,324 per month with a 3% increase each year, or $3,461,568 in total. The Company recorded the present value of the lease payments over the term as a lease liability and an ROU asset. The Company’s incremental borrowing rate of 7% was used as the discount rate since the rate implicit in the lease was not readily determinable.

 

The lease liability related to this operating lease, which represents the present value of the lease payments, and the corresponding ROU asset were both $2,341,339 at inception of the lease. As of March 31, 2026, the ROU asset was $2,067,018 (December 31, 2025 - $2,111,027) and the lease liability was $2,586,253 (December 31, 2025 - $2,543,723). During the three months ended March 31, 2026, the Company recognized $86,539 (2025 – nil) of lease expense related to this lease in “Selling, general and administrative” in the consolidated statements of income and comprehensive income. There were no payments made or expense recorded for this lease in 2024. The Company is waiting for final requirements to be met by the lessor before starting to pay rent. At December 31, 2025 and March 31, 2026, the difference between the ROU asset and lease liability is attributable to the timing of the commencement of rent payments.

 

Mendota, Illinois Operating Leases

 

In October 2025, in connection with the sale of a building previously occupied by the Company’s subsidiary ENP Investments (see Note 6), ENP Investments entered into operating leases with the new owner for a total of 125,500 square feet of manufacturing and office space, comprised of two lease sections. The Company’s incremental borrowing rate of 7% was used as the discount rate for both leases as the implicit rate was not readily determinable.

 

Section A (110,000 sq. ft.): Initial term of 60 months with an option to renew. Monthly base rent begins at $27,492 and escalates at approximately 3.6% annually, for total undiscounted payments of $1,771,552. At inception, both the ROU asset and lease liability were recorded at $1,483,227. The option to renew was not considered in calculating the initial carrying values. As of March 31, 2026, both the ROU asset and lease liability were $1,368,664 (December 31, 2025 - $1,426,447). For the three months ended March 31, 2026, operating lease expense of $82,475 (2025 – $nil) was recognized in “Cost of sales” in the condensed interim consolidated statements of loss and comprehensive income (loss).

 

Section B (15,500 sq. ft.): Initial term of 60 months with an option to renew. Monthly base rent begins at $4,856 and escalates at approximately 3.6% annually, for total undiscounted payments of $312,625. At inception, both the ROU asset and lease liability were recorded at $263,383. The option to renew was not considered in calculating the initial carrying values. As of March 31, 2026, both the ROU asset and lease liability were $242,870 (December 31, 2025 - $253,213). For the three months ended March 31, 2026, operating lease expense of $14,567 (2025 – $nil) was recognized in “Cost of sales” in the condensed interim consolidated statements of loss and comprehensive income (loss).

 

The following table summarizes expense and cash payments for operating leases during the periods noted:

 

   Three months ended March 31, 
   2026   2025 
Operating lease expense  $183,581   $- 
Cash paid for rents with terms less than 1 year  $16,850   $22,160 
Cash paid for operating lease liability  $97,041   $- 

 

The following table contains the weighted average remaining lease term and discount rate for operating leases as of the end of the period:

 

  

As of

March 31, 2026

 
Remaining lease term – Panama operating lease   8.5 years 
Remaining lease term – Mendota, IL operating leases   4.5 years 
Discount rate - operating leases   7.0%

 

11

 

 

The table below presents a maturity analysis of the future minimum lease payments for operating leases as of March 31, 2026:

  

Twelve months ending December 31,  Total 
Remainder of 2026  $482,597 
2027   787,376 
2028   813,094 
2029   753,349 
2030   672,417 
Thereafter   1,677,458 
Total operating lease payments   5,186,291 
Less: discount on lease liability   (988,504)
Total operating lease liability   4,197,787 
Less: current portion of operating lease liability   (466,972)
Non-current operating lease liability  $3,730,815 

 

4. ACCOUNTS RECEIVABLE

  

   March 31,
2026
  

December 31,
2025

 
         
Accounts receivable  $13,679,635   $12,910,754 
Allowances for doubtful accounts   (289,247)   (288,853)
Total accounts receivable  $13,390,388   $12,621,901 

 

5. INVENTORIES

 

 

   March 31,
2026
   December 31,
2025
 
         
Completed goods  $2,358,839   $2,090,720 
Works in progress   194,792    231,407 
Raw materials and supplies   9,968,725    8,219,510 
Total inventory  $12,522,356   $10,541,637 

 

6. PROPERTY, EQUIPMENT AND LEASEHOLDS

 

   March 31, 2026   Accumulated   March 31, 2026 
   Cost   Depreciation   Net 
Buildings and improvements  $11,219,850   $5,039,730   $6,180,120 
Automobiles   173,659    97,956    75,703 
Office equipment   148,702    121,732    26,970 
Manufacturing equipment   19,719,651    8,395,110    11,324,541 
Land   299,027        299,027 
Technology   98,005    98,005     
   $31,658,894   $13,752,533   $17,906,361 

 

   December 31, 2025   Accumulated   December 31, 2025 
   Cost   Depreciation   Net 
Buildings and improvements  $11,087,175   $4,904,582   $6,182,593 
Automobiles   190,933    108,304    82,629 
Office equipment   133,990    121,386    12,604 
Manufacturing equipment   17,636,508    8,071,269    9,565,239 
Land   299,027        299,027 
Technology   99,671    99,671     
   $29,447,304   $13,305,212   $16,142,092 

 

Amount of depreciation expense for three months ended March 31, 2026 was: $469,495 (2025 - $425,198) and is included in cost of sales in the condensed interim consolidated statements of operations and comprehensive income (loss).

 

In late 2025, management committed to a plan to sell the 14,000 sq. ft. former manufacturing facility located in Mendota, IL. As of March 31, 2026 and December 31, 2025, the carrying value of the property has been reclassified to Property Held for Sale on the consolidated balance sheet at its estimated net realizable value of $425,000.

 

12

 

 

7. INVESTMENTS

 

The Company’s investments at March 31, 2026 and December 31, 2025 consisted of the following:

 

SCHEDULE OF COMPANY’S INVESTMENTS 

   March 31, 2026   December 31, 2025 
         
Investments, at cost:          
Trio Opportunity Corp., 47,000 non-voting Class B shares  $470,000   $470,000 
Investment, equity method:          
Florida-based LLC   1,530,236    1,584,324 
Total  $2,000,236   $2,054,324 

 

In January 2019, the Company invested in a Florida based LLC that is engaged in international sales of fertilizer additives. According to the operating agreement, the Company had a 50% interest in the profit and loss of the Florida based LLC but did not have control. In August 2024, the Company sold a 30.1% interest in the Florida based LLC to a third party for consideration of $2,000,000. In addition, the Company entered into a subsequent agreement for the sale of its remaining 19.9% interest over the next five years for an additional $4,000,000. Starting in 2025, the Company will sell a further 3.98% per year upon receipt of that year’s $800,000 payment. In December 2025, the purchaser advised that there would be a delay in funding the 2025 tranche and that they would pay the $100,000 penalty in January 2026. This payment was made by the Florida based LLC, and not the third party, and was applied to the outstanding Accounts Receivable due from the Florida based LLC. At March 31, 2026, the Company continues to account for this investment using the equity investment as it exercises significant influence.

 

A summary of the activity associated with the Company’s investment in the Florida based LLC during the three months ended March 31, 2026 and the year ended December 31, 2025 is follows:

 

Balance, December 31, 2024 – 19.9% interest  $1,454,381 
Company’s proportionate share of earnings   129,943 
Balance, December 31, 2025 – 19.9% interest  $1,584,324 
Company’s proportionate share of loss   (54,088)
Balance, March 31, 2026 – 19.9% interest  $1,530,236 

 

Summarized profit and loss information related to the Florida based LLC is as follows:

 

   Three months ended
March 31, 2026
   Three months ended
March 31, 2025
 
         
Net sales  $1,620,695   $3,443,030 
Gross profit  $323,949   $1,094,892 
Net income (loss)  $(271,797)  $321,229 

 

During the three months ended March 31, 2026, the Company had sales of $498,418 (2025 - $1,856,395) to the Florida based LLC. At March 31, 2026, the Florida based LLC had a balance of $592,188 included within Accounts Receivable (December 31, 2025 - $980,638).

 

13

 

 

8. SHORT TERM LINES OF CREDIT

 

(a) In June 2025, ENP Investments renewed the line of credit with Stock Yards Bank and Trust (“Stock Yards”). The revolving line of credit is for an aggregate amount of up to the lesser of (i) $5,000,000, or (ii) 50-80% of eligible domestic accounts receivable plus 50% of inventory, capped at $2,500,000. Interest on the unpaid principal balance of this loan will be calculated using the greater of prime or 4.0%. The interest rate at March 31, 2026 is 6.75% (December 31, 2025 – 6.75%).

 

The revolving line of credit contains customary affirmative and negative covenants, including the following: compliance with laws, provisions of financial statements and periodic reports, payment of taxes, maintenance of inventory and insurance, maintenance of operating accounts at Stock Yards, Stock Yard’s access to collateral, formation or acquisition of subsidiaries, incurrence of indebtedness, dispositions of assets, granting liens, changes in business, ownership or business locations, engaging in mergers and acquisitions, making investments or distributions and affiliate transactions. NanoChem is a guarantor of 65% of all the principal and other loan costs not to exceed $3,250,000. The non-controlling interest is the guarantor of the remaining 35% of all the principal and other loan costs not to exceed $1,750,000.

 

To secure the repayment of any amounts borrowed under the revolving line of credit, the Company granted Stock Yards a security interest in substantially all of the assets of ENP Investments, exclusive of intellectual property assets.

 

The balance outstanding under this revolving line as of March 31, 2026 was $3,812,187 (December 31, 2025 - $2,092,097).

 

(b) In August 2025, the Company renewed the line of credit with Stock Yards Bank and Trust (“Stock Yards”). The revolving line of credit is for an aggregate amount of up to the lesser of (i) $2,000,000, or (ii) 80% of eligible domestic accounts receivable plus 50% of inventory, capped at $1,000,000. Interest on the unpaid principal balance of this loan will be calculated using the greater of prime or 4.0%. The interest rate at March 31, 2026 is 6.75% (December 31, 2025 – 6.75%).

 

The revolving line of credit contains customary affirmative and negative covenants, including the following: compliance with laws, provision of financial statements and periodic reports, payment of taxes, maintenance of inventory and insurance, maintenance of operating accounts at Stock Yards, Stock Yards access to collateral, formation or acquisition of subsidiaries, incurrence of indebtedness, dispositions of assets, granting liens, changes in business, ownership or business locations, engaging in mergers and acquisitions, making investments or distributions and affiliate transactions. The covenants also require that the Company maintain a minimum ratio of qualifying financial assets to the sum of qualifying financial obligations.

 

To secure repayment of any amounts borrowed under the revolving line of credit, the Company granted Stock Yards a security interest in substantially all of the assets of NanoChem, exclusive of intellectual property assets.

 

The balance outstanding under this revolving line as of March 31, 2026 was $984,257 (December 31, 2025 - $56,289).

 

14

 

 

9. LONG TERM DEBT

 

Long term debt, all of which is with StockYards Bank and Trust, at March 31, 2026 and December 31, 2025 consisted of the following:

 

   March 31, 2026   December 31, 2025 
ENP Mendota, 10-year mortgage, 5 year fixed index plus 4.50% interest (7.18%) monthly payments through to January 2030, collateralized by real property and all rents on said property  $343,714   $351,377 
ENP Peru, 10-year mortgage, 7.18% interest, monthly principal and interest payments through January 2030, collateralized by real property (1st mortgage)   2,579,168    2,595,681 
ENP Peru, 10-year mortgage, 5.4% interest, monthly principal payments plus interest through June 2032, collateralized by real property (2nd mortgage)   235,556    237,317 
NanoChem, 5-year note payable, 7.0% interest, monthly principal payments plus interest through August 2029, collateralized by manufacturing equipment   1,181,586    1,257,285 
Long-term debt   4,340,024    4,441,660 
Less: current portion   (414,205)   (396,961)
Long-term debt non current  $3,925,819   $4,044,699 

 

The following table summarizes the scheduled annual future principal payments as of March 31, 2026:

 

SCHEDULE OF ANNUAL FUTURE PRINCIPAL PAYMENTS 

Year Ended December 31,  Principal
Amount Due
 
Remainder of 2026  $313,972 
2027   443,446 
2028   472,599 
2029   375,772 
2030   2,254,887 
Thereafter   479,348 
Total  $4,340,024 

 

10. STOCK BASED COMPENSATION

 

During the three months ended March 31, 2026 and 2025, the Company recognized stock based compensation associated with stock options as follows:

 

   March 31, 2026   March 31, 2025 
Line item on the statement of operations and comprehensive income (loss):          
Wages, administrative salaries and benefits  $87,443   $79,740 
Professional fees   22,330    18,180 
Stock based compensation  $109,773   $97,920 

 

The following table summarizes the Company’s stock option activities for the three months ended March 31, 2026 and the full year ended December 31, 2025:

 

   Number of
shares
   Exercise price
per share
   Weighted average
exercise price
 
             
Balance, December 31, 2024   1,850,000   $2.004.05   $2.68 
Granted   66,000   $7.00   $7.00 
Cancelled or expired   (5,000)  $2.003.61   $2.84 
Exercised   (212,000)  $2.003.61   $2.80 
Balance, December 31, 2025   1,699,000   $2.007.00   $2.83 
Exercised   (15,000)  $2.444.05   $3.35 
Balance, March 31, 2026   1,684,000   $2.007.00   $2.84 
Exercisable, March 31, 2026   1,068,000   $2.007.00   $2.75 

 

15

 

 

During the three months ended March 31, 2026 and 2025, the Company did not grant any stock based compensation to employees or consultants.

 

As of March 31, 2026, the weighted-average remaining contractual life of outstanding and exercisable options is 2.5 years and 2.3 years, respectively. As of March 31, 2026, there was approximately $302,111 of compensation expense related to non-vested options that is expected to be recognized over a weighted average period of 1.2 years.

 

The aggregate intrinsic value of options outstanding and exercisable at March 31, 2026 is $4,317,960 and $2,832,560, respectively. During the three months ended March 31, 2026, the intrinsic value of stock options exercised was $49,000 (2025 - $419,350).

 

During the year ended December 31, 2025, the Company granted 50,000 shares as a stock award. The total fair value of the stock award was $350,000 with 10,000 shares vested upon issuance and 10,000 shares vest on each anniversary date through 2029. As of March 31, 2026, there was approximately $217,440 of compensation related to the 40,000 non-vested shares of the stock award that is expected to be recognized through 2029.

 

11. CAPITAL STOCK

 

During the three months ended March 31, 2026, 15,000 shares were issued upon the exercise of stock options (2025 – 132,000).

 

12. NON-CONTROLLING INTERESTS

 

(a) ENP Investments is a limited liability corporation (“LLC”) that manufactures and distributes golf, turf and ornamental agriculture products in Mendota, Illinois. The Company owns a 65% interest in ENP Investments through its wholly-owned subsidiary NanoChem. An unrelated party (“NCI”) owns the remaining 35% interest in ENP Investments. ENP Mendota is a wholly owned subsidiary of ENP Investments. ENP Mendota is a LLC that leases warehouse space. For financial reporting purposes, the assets, liabilities and earnings of both of the LLC’s are consolidated into these financial statements. The NCI’s ownership interest in ENP Investments is recorded in non-controlling interests in these condensed interim consolidated financial statements. The non-controlling interest represents NCI’s interest in the earnings and equity of ENP Investments. ENP Investments is allocated to the TPA segment. See Note 13.

 

ENP Investments makes cash distributions to its equity owners based on formulas defined within its Ownership Interest Purchase Agreement dated October 1, 2018. Distributions are defined in the Ownership Interest Purchase Agreement as cash on hand to the extent it exceeds current and anticipated long-term and short-term needs, including, without limitation, needs for operating expenses, debt service, acquisitions, reserves, and mandatory distributions, if any.

 

From the effective date of acquisition onward, the minimum distributions requirements under the Ownership Interest Purchase Agreement were satisfied. The total distribution from the effective date of acquisition onward was $4,862,387.

  

Balance, December 31, 2024  $3,270,514 
Distribution   (841,708)
Non-controlling interest share of income   1,425,782 
Balance, December 31, 2025   3,854,588 
Non-controlling interest share of loss   (41,937)
Balance, March 31, 2026  $3,812,651 

 

During the three months ended March 31, 2026, the Company had sales of $895,953 (2025 - $830,483) to NCI. At March 31, 2026, the NCI had a balance of $7,554,641 included within Accounts Receivable (December 31, 2025 – $6,652,611).

 

16

 

 

b) 317 Mendota was a LLC that owned real estate that the Company occupied part of while the excess was rented out. In October 2025, the Company sold the building but continues to rent from the new owner (see Note 3). 317 Mendota was dissolved in March 2026. In connection with the dissolution, the Company received $72,953 in cash. The transaction was accounted for as an equity transaction, with the Company’s share recorded as capital in excess of par value; no gain or loss was recognized in the consolidated statements of operations. The Company owned an 80% interest in 317 Mendota and an unrelated party (“317 NCI”) owned the remaining 20% interest in 317 Mendota. For financial reporting purposes, the assets, liabilities and earnings of 317 Mendota were consolidated into these financial statements. The 317 NCI’s ownership interest in 317 Mendota was recorded in non-controlling interests in these condensed interim consolidated financial statements. The non-controlling interest represented 317 NCI’s interest in the earnings and equity of 317 Mendota.

  

Balance, December 31, 2024  $63,540 
Distribution   (150,000)
Non-controlling interest share of income   155,119 
Balance, December 31, 2025   68,659 
Distribution   (68,659)
Balance, March 31, 2026  $- 

 

13. SEGMENTED DISCLOSURE, SIGNIFICANT CUSTOMER INFORMATION AND ECONOMIC DEPENDENCY

 

The Company operates in two segments:

 

(a) Energy and water conservation products (as shown under the column heading “EWCP” below), which consists of a (i) liquid swimming pool blankets which save energy and water by inhibiting evaporation from the pool surface, and (ii) food-safe powdered form of the active ingredient within the liquid blankets and which are designed to be used in still or slow moving drinking water sources.

 

(b) Biodegradable polymers, also known as TPA’s (as shown under the column heading “BCPA” below), used by the petroleum, chemical, utility and mining industries to prevent corrosion and scaling in water piping. This product can also be used in detergents to increase biodegradability and in agriculture to increase crop yields by enhancing fertilizer uptake.

 

The third product line is nitrogen conservation products used for the agriculture industry. These products decrease the loss of nitrogen fertilizer after initial application and allows less fertilizer to be used. These products are made and sold by the Company’s TPA division.

 

The Company also manufactures food grade products that are made and sold by the TPA division.

 

The Company’s reportable segments are strategic business units that offer different, but synergistic products and services. They are managed separately because each business requires different technology and marketing strategies. The economic factors that impact the nature, amount, timing, and uncertainty of revenue and cash flows vary among the Company’s operating segments and the geographical regions in which they operate. This operating segment structure is used by the Chief Operating Decision Maker (“CODM”), who has been determined to be the Chief Executive Officer, to make key operating decisions and assess performance of the Company. The CODM evaluates segment operating performance, and makes resource allocation and performance evaluation decisions, based on gross profit and net operating income.

 

Three months ended March 31, 2026:

 

   EWCP   BCPA   Other (1)   Consolidated 
Product Sales  $104,573   $8,192,424   $-   $8,296,997 
Cost of sales   66,478    6,341,213    -    6,407,691 
Gross profit   38,095    1,851,211    -    1,889,306 
Wages, administrative salaries and benefits   32,968    994,118    -    1,027,086 
Selling, general, and administrative   18,147    679,676    64,534    762,357 
Other segment items (2)   0    213,947    (28,119)   185,828 
Operating loss   (13,020)   (36,530)   (36,415)   (85,965)
Interest expense   -    134,069    -    134,069 
Depreciation and amortization (included in COGS)   2,928    506,567    -    509,495 
Capital expenditures   -    2,233,765    -    2,233,765 
Assets at March 31, 2026 (3)   1,570,655    61,075,433    1,285,475    63,931,563 

 

17

 

 

Three months ended March 31, 2025:

 

   EWCP   BCPA   Other (1)   Consolidated 
Sales  $40,185   $7,433,507   $-   $7,473,692 
Cost of sales   49,797    5,472,331    -    5,522,128 
Gross profit (loss)   (9,612)   1,961,176    -    1,951,564 
Wages, administrative salaries and benefits   17,593    877,644    -    895,237 
Selling, general, and administrative   27,265    685,859    42,926    756,050 
Other segment items (2)   6,000    235,033    128,401    369,434 
Operating income (loss)   (60,470)   162,640    (171,327)   (69,157)
Interest expense   -    198,019    -    198,019 
Depreciation and amortization (included in COGS)   3,206    461,992    -    465,198 
Capital expenditures   -    354,121    -    354,121 
Assets at December 31, 2025 (3)   2,097,454    58,533,323    1,201,602    61,832,379 

 

(1)   Other is not considered an operating segment and includes expenses and income not identifiable to an operating segment and is not included in operating segment results
     
(2)   Other segment items for each reportable segment includes items such as professional fees and research and development.
     
(3)   Segment assets include cash, term deposits, accounts receivable, inventory, prepaid expenses, property held for sale, property, equipment and leaseholds, right of use assets, intangible assets, long-term deposits, investments and goodwill.

 

Sales by territory are shown below:

    

   Three months ended
March 31, 2026
   Three months ended
March 31, 2025
 
         
Canada  $88,292   $288,094 
United States and abroad   8,208,705    7,185,598 
Total  $8,296,997   $7,473,692 

 

The Company’s long-lived assets (property, equipment and leaseholds, right of use assets, intangibles, and goodwill) by territory as follows:

    

  

March 31, 2026

  

December 31, 2025

 
         
Canada  $103,729   $108,423 
United States and abroad   25,935,459    24,318,631 
Total  $26,039,188   $24,427,054 

 

Three primary customers accounted for $4,639,124 (56%) of sales during the three-month period ended March 31, 2026 (2025 - $3,665,235 or 49%).

 

14. SUBSEQUENT EVENTS

 

None.

 

18

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Overview

 

The Company manufactures and markets biodegradable polymers which are used in the oil, gas and agriculture industries. The Company also develops, manufactures and markets specialty chemicals that slow the evaporation of water.

 

Results of Operations

 

The first is a chemical (“EWCP”) used in swimming pools and spas. The product forms a thin, transparent layer on the water’s surface. The transparent layer slows the evaporation of water, allowing the water to retain a higher temperature for a longer period of time thereby reducing the energy required to maintain the desired temperature of the water. A modified version of EWCP can also be used in reservoirs, potable water storage tanks, livestock watering pods, canals, and irrigation ditches for the purpose of reducing evaporation.

 

The second product, biodegradable polymers (“TPAs”), is used by the petroleum, chemical, utility and mining industries to prevent corrosion and scaling in water piping. TPAs can also be used to increase biodegradability in detergents and in the agriculture industry to increase crop yields by enhancing fertilizer uptake.

 

The third product line is nitrogen conservation products used for the agriculture industry. These products decrease the loss of nitrogen fertilizer after initial application and allows less fertilizer to be used. These products are made and sold by the Company’s TPA division.

 

The Company also manufactures food grade products that are made and sold by the TPA division.

 

Material changes in the Company’s Statement of Operations for three months ended March 31, 2026 compared to the same period in the prior year are discussed below:

 

Three Months ended March 31, 2026

 

Item  

Increase (I) or

Decrease (D)

  Reason
         
Sales        
EWCP products   I   Increased customer orders.
         
TPA products   I  

Increased customer orders.

 

Gross profit as a percentage of sales   D   Increased costs associated with scaling up new products and a new manufacturing location along with an increase in sales of lower margins products in 2026 over 2025.
         
Professional fees   D   Q1 2025 included audit fees relative to the 2024 audit that were underaccrued.
         
Wages, administrative salaries and benefits   I   Increase in employees in the TPA division.
         
Income on investment   D   The investee in which the Company applies the equity method, had a net loss for the period as opposed to net income as in prior year.
         
Interest expense   D   Decreased debt resulted in decreased interest expense.
         
Interest income   D   Decrease in term deposits held.
         
Income tax expense   D   The BPCA division recorded an operating loss in Q1 2026 which resulted in lower income taxes assessed than what was recorded in Q1 2025.

 

19

 

 

Three primary customers accounted for 56% of the Company’s sales during the three months ended March 31, 2026 (2025 - 49%). The amount of revenue (all from the sale of TPA products) attributable to each customer is shown below.

 

   Three Months Ended March 31, 
   2026   2025 
         
Company A  $895,953   $830,483 
Company B  $498,418*  $1,856,395 
Company C  $1,163,662   $978,357 
Company D  $2,579,509   $-*

 

*not a primary customer in that period

 

Customers with balances greater than 10% of our receivables as of March 31, 2026 and December 31, 2025 are shown below:

 

  

March 31,
2026

  

December 31,
2025

 
         
Company A  $7,554,641   $6,652,611 
Company D  $1,015,838*  $1,866,972 

 

*less than 10% at period end

 

Other factors that will most significantly affect future operating results will be:

 

  the sale price of crude oil which is used in the manufacture of aspartic acid we import from China. Aspartic acid is a key ingredient in our TPA products;
     
  activity in the oil and gas industry, as we sell our TPA products to oil and gas companies;
     
  drought conditions, since we also sell our TPA products to farmers; and
     
  new tariffs relating to raw materials imported from China.

 

Other than the foregoing we do not know of any trends, events or uncertainties that have had, or are reasonably expected to have, a material impact on our revenues or expenses.

 

20

 

 

Capital Resources and Liquidity

 

The Company’s sources and (uses) of cash for the three months ended March 31, 2026 and 2025 are shown below:

 

   2026   2025 
         
Cash used in operating activities   (1,818,177)   (544,294)
Maturities of term deposits   733,340    1,019,760 
Purchase of property, equipment and leaseholds   (2,233,765)   (354,121)
Proceeds of short-term lines of credit, net   2,648,058    1,938,670 
Repayment of long term debt   (101,636)   (616,343)
Distributions to non-controlling interest   (68,659)   - 
Distribution received upon dissolution of subsidiary   72,953    - 
Proceeds from shares issued upon exercise of stock options   50,200    381,690 
Effect of exchange rate changes on cash   (86,283)   188,840 

 

The Company has sufficient cash resources to meets its future commitments and cash flow requirements for the coming year. As of March 31, 2026, working capital was $20,878,345 (December 31, 2025 - $22,173,434) and the Company has no substantial commitments that require significant outlays of cash over the coming fiscal year.

 

The Company does not anticipate any capital requirements for the twelve months ending March 31, 2027.

 

We do not know of any trends, demands, commitments, events or uncertainties that will result in, or that are reasonable likely to result in, our liquidity increasing or decreasing in any material way.

 

Other than as disclosed above, we do not know of any significant changes in our expected sources and uses of cash.

 

We do not have any commitments or arrangements from any person to provide us with any equity capital.

 

There have been no significant changes to the critical accounting estimates disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our 2025 Form 10-K.

 

Item 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Under the direction and with the participation of our management, including our Principal Executive and Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2026. We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports with the Securities and Exchange Commission is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and regulations, and that such information is accumulated and communicated to our management, including our principal executive and financial officer, as appropriate, to allow timely decisions regarding required disclosure. Our disclosure controls and procedures are designed to provide a reasonable level of assurance of reaching desired disclosure control objectives. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were ineffective. In 2026, the Company will implement new procedures to improve its disclosure controls and procedures.

 

Changes in Internal Control over Financial Reporting

 

At December 31, 2025, management identified material weaknesses in our internal control over financial reporting (“ICFR”) related to a material adjustment identified during the audit process indicating that controls over the financial statement close and review process were not operating effectively to prevent or detect misstatements on a timely basis. Because of the material weaknesses described above, we implemented new procedures to improve our financial statement close and review process during the quarter ended March 31, 2026. Remediation is in progress and is anticipated to be fully in place by the fourth quarter of 2026.

 

21

 

 

PART II

 

Item 5. Other Information

 

None of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarterly period ending March 31, 2026

 

Item 6. Exhibits.

 

Number   Description
3.1   Articles of Continuance (Articles of Incorporation) (1)
3.2   Bylaws (2)
31.1   Certification of Principal Executive Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.*
31.2   Certification of Principal Financial Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.*
32.1   Certification of Principal Executive and Financial Officer Pursuant to 18 U.S.C. §1350 and §906 of the Sarbanes-Oxley Act of 2002.*
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed with this report.

 

(1) Incorporated by reference the same exhibit filed with the Company’s March 31, 2022 10-Q report.
   
(2) Incorporated by reference to Exhibit 3(ii) filed the Company’s 8-K report dated April 10, 2022.

 

22

 

 

SIGNATURES

 

In accordance with the requirements of Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

May 15, 2026

 

  Flexible Solutions International, Inc.
     
  By: /s/ Daniel B. O’Brien
  Name: Daniel B. O’Brien
  Title: President and Principal Executive Officer
     
  By: /s/ Daniel B. O’Brien
  Name: Daniel B. O’Brien
  Title: Principal Financial and Accounting Officer

 

23